DCPH:US
$25.59
-
0.00%

Deciphera Pharmaceuticals Inc.
News & Events

Last updated: May 11, 2025, 7:49 AM ET

  1. BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RBAZ Bancorp, Inc. (OTCPK - RBAZ), Squarespace, Inc. (NYSE - SQSP), PlayAGS, Incorporated (NYSE - AGS), Deciphera Pharmaceuticals, Inc. (Nasdaq - DCPH)

    GlobeNewswire JUN 18, 2024 10:59 AM EDT
    BALA CYNWYD, Pa., June 18, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the ...
    READ ARTICLE
  2. Deciphera Pharmaceuticals Announces Oral Presentation of Results from MOTION Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the 2024 ASCO Annual Meeting and Online Publication in The Lancet

    Business Wire JUN 3, 2024 7:00 AM EDT
    – MOTION Phase 3 Data Demonstrate Robust Efficacy, Clinically Meaningful Improvements in Q...
    READ ARTICLE
  3. SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SQSP, AGS, DCPH

    GlobeNewswire MAY 30, 2024 9:11 AM EDT
    NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is inve...
    READ ARTICLE
  4. BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RBAZ Bancorp, Inc. (OTCPK - RBAZ), Squarespace, Inc. (NYSE - SQSP), PlayAGS, Incorporated (NYSE - AGS), Deciphera Pharmaceuticals, Inc. (Nasdaq - DCPH)

    GlobeNewswire MAY 30, 2024 8:06 AM EDT
    BALA CYNWYD, Pa., May 30, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the f...
    READ ARTICLE
  5. STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - DCPH, DPSI, AIRC, DRQ

    GlobeNewswire MAY 29, 2024 11:32 AM EDT
    NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the ȁ...
    READ ARTICLE
  6. BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RBAZ Bancorp, Inc. (OTCPK - RBAZ), Squarespace, Inc. (NYSE - SQSP), PlayAGS, Incorporated (NYSE - AGS), Deciphera Pharmaceuticals, Inc. (Nasdaq - DCPH)

    GlobeNewswire MAY 20, 2024 9:21 AM EDT
    BALA CYNWYD, Pa., May 20, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the f...
    READ ARTICLE
  7. SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DCPH, HTLF, UMBF, TBNK

    ACCESS Newswire APR 30, 2024 1:30 PM EDT
    NEW YORK, NY / ACCESSWIRE / April 30, 2024 / Halper Sadeh LLC, an investor rights law firm, is i...
    READ ARTICLE
  8. SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Deciphera Pharmaceuticals, Inc. Buyout

    Newsfile APR 29, 2024 3:23 PM EDT
    Wilmington, Delaware--(Newsfile Corp. - April 29, 2024) - Rigrodsky Law, P.A. is investigating De...
    READ ARTICLE
  9. Medison Pharma Announces Public Formulary Listing of QINLOCK® (ripretinib) in Canadian Provinces: Ontario and Quebec for Advanced Gastrointestinal Stromal Tumor (GIST) Treatment

    Canada Newswire SEP 29, 2023 9:00 AM EDT
    Medison Pharma Announces Public Formulary Listing of QINLOCK® (ripretinib) in Canadian Provi...
    READ ARTICLE

Upcoming Events

Get notified of Deciphera Pharmaceuticals Inc.’s latest announcements, news, and event dates.
  • Upcoming earnings announcement

    Not Available
  • Upcoming dividend payout

    Not Available
  • Upcoming stock splits

    Not Available